Advertisement

STEMCELL Technologies Inc. Company Profile

01:03 EDT 21st May 2013 | BioPortfolio

STEMCELL Technologies Inc. is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research. Driven by science and enabled by close interactions with global leaders in cell biology and medicine, STEMCELL delivers over 1000 products to research scientists in more than 70 countries worldwide. To learn more about how STEMCELL helps to make research work, visit www.stemcell.com.


News Articles [ 10 Associated News Articles listed on BioPortfolio]

STEMCELL Technologies Announces the Release of PneumaCult™-ALI, a New Culture Medium for Differentiating Human Bronchial Epithelial Cells at the Air-liquid Interface

The development of convenient, yet physiologically relevant in vitro culture systems is critical to research and development on chronic respiratory diseases such as asthma or COPD, and could accelerat...

New Products to Advance Research on Human Pluripotent Stem Cells

STEMCELL Technologies Inc. (STEMCELL) announced today its plans to release a series of new products to advance research and translational applications for human pluripotent stem c...

Precision StemCell's Revolutionary InVivo Adult Stem Cell Reprogramming Procedure Shows Potential for Treating ALS

GULF SHORES, Ala., July 26, 2012 /PRNewswire/ -- Eight years ago, Frank Orgel, a former NFL football player and college coach, was diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou...

Nobel laureate Yamanaka warns of rogue "stemcell therapies"

HONG KONG (Reuters) - Nobel laureate Shinya Yamanaka warned patients on Tuesday about unproven "stem cell therapies" offered at clinics and hospitals in a growing number of countries, saying they were...

Military Veteran with Spinal Cord Injury Is First Patient to Receive Intraspinal Injections of Reprogramed Stem Cell Therapy from Precision StemCell

GULF SHORES, Ala., Jan 8, 2013 /PRNewswire/ -- In 2007, an ATV accident left military veteran Scott Williams with a spinal cord injury that paralyzed him from the upper chest down. In the summer...

Precision StemCell's Neural Reprogrammed Stem Cell Therapy Yields Better-Than-Expected Results for ALS Patients

GULF SHORES, Ala., Dec. 4, 2012 /PRNewswire/ -- More than 75 percent of amyotrophic lateral sclerosis (ALS) patients who received neural reprogrammed stem cell therapy have shown a positive respo...

PTV News: Dec 3, 2009

Top stories on December 3rd, 2009: AZ in billion dollar deal for Targacept's antidepressant Roche's diabetes drug "better than Merck's Januvia" Dyax shares skyrocket on FDA approval of Kalbitor...

Pantec Biosolutions Closes CHF 20 Million Financing

Ruggell, Liechtenstein, 20 July 2010- Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, today announced the closing of a CHF 20 m...

Drugs and Medications [0 Results]

None

PubMed Articles [ 1 Associated PubMed Articles listed on BioPortfolio]

Roles of the hypoxia response system in hematopoietic and leukemic stem cells.

Stem cells exhibit a number of characteristic features, including the capacity for self-renewal and differentiation into multiple cell types, stress resistance, and drug efflux activity. These specifi...

Clinical Trials [ 2 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy

1. Scientific background In patients with multiple myeloma high-dose chemotherapy followed by autologous stemcell transplantation is preferred to conventional therapy, since the...

Intra Bone Marrow Injection Of Unrelated Cord Blood Cells

Compared to other stemcell sources cord blood (CB) is easier and safer to procure, has no donor attrition, a limitless supply, reduced viral transmission, less acute & chronic GVHD, is ric...

Companies [ 6 Associated Companies listed on BioPortfolio]

STEMCELL Technologies Inc.

STEMCELL Technologies Inc. is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research....

StemCell Technologies Incorporated

StemCell Technologies Inc is a privately owned, market-driven biotechnology company located in Vancouver, British Columbia. StemCell provides highly specialized media and cell separation products that...

StemCell Technologies

StemCell Technologies is committed to supporting stem cell and many other areas of life science research worldwide by providing enabling research tools that are innovative, timely and of consistently...

StemCell Technologies, Inc

StemCell Technologies is a world leader in the development of products for stem cell biology and has worked to standardize the field through the Global Proficiency Testing Program. Combining StemCell...

StemCell Technologies Contract Services

Combining StemCell Technologies' industry standard reagents and a scientific team of experts in bone marrow assays and stem cell biology, we are proud to assist organizations in drug development, agro...

More Information about "STEMCELL Technologies Inc." on BioPortfolio

We have published hundreds of STEMCELL Technologies Inc. news stories on BioPortfolio along with dozens of STEMCELL Technologies Inc. Clinical Trials and PubMed Articles about STEMCELL Technologies Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of STEMCELL Technologies Inc. Companies in our database. You can also find out about relevant STEMCELL Technologies Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement